Prevention of vertical transmission of HIV-1 in resource-limited settings (Q22241479)

PubMed

7 February 2023

Leith Kwaan

2

Leith

Kwaan

1 reference

PubMed

7 February 2023

Mairi Thomson

3

author given names

Mairi

author last names

Thomson

1 reference

PubMed

full work available at URL

7 February 2023

language of work or name

English

0 references

publication date

October 2010

0 references

http://www.future-drugs.com/doi/abs/10.1586/eri.10.94

online access status

open access

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20954881

http://www.tandfonline.com/doi/pdf/10.1586/eri.10.94

4 August 2024

1 reference

Expert Review of Anti-infective Therapy

4 August 2024

published in

0 references

volume

8

0 references

issue

10

0 references

page(s)

1163-1175

0 references

cites work

Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire

1 reference

Timing and determinants of mother-to-child transmission of HIV in Nigeria

21 January 2018

1 reference

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

21 January 2018

1 reference

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

21 January 2018

1 reference

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

21 January 2018

1 reference

Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy

21 January 2018

1 reference

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

21 January 2018

1 reference

Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China

21 January 2018

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

21 January 2018

1 reference

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

21 January 2018

1 reference

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

21 January 2018

1 reference

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention

21 January 2018

1 reference

Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania

21 January 2018

1 reference

A randomized trial to determine the optimal dosage of multivitamin supplements to reduce adverse pregnancy outcomes among HIV-infected women in Tanzania

21 January 2018

1 reference

A systematic review of randomized controlled trials of prenatal and postnatal vitamin A supplementation of HIV-infected women

21 January 2018

1 reference

Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania

21 January 2018

1 reference

Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality

21 January 2018

1 reference

Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania

21 January 2018

1 reference

Zinc supplementation to HIV-1-infected pregnant women: effects on maternal anthropometry, viral load, and early mother-to-child transmission

21 January 2018

1 reference

Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission

21 January 2018

1 reference

Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group

21 January 2018

1 reference

15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery

21 January 2018

1 reference

How many child deaths can we prevent this year?

21 January 2018

1 reference

Exclusive breastfeeding reduces acute respiratory infection and diarrhea deaths among infants in Dhaka slums

21 January 2018

1 reference

Effect of community-based promotion of exclusive breastfeeding on diarrhoeal illness and growth: a cluster randomised controlled trial

21 January 2018

1 reference

Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus

21 January 2018

1 reference

Breast feeding: A time to craft new policies

21 January 2018

1 reference

A metasynthesis of qualitative breastfeeding studies

21 January 2018

1 reference

Breastfeeding and AIDS in the developing world

21 January 2018

1 reference

Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission

21 January 2018

1 reference

Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.

21 January 2018

1 reference

18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission

21 January 2018

1 reference

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire

21 January 2018

1 reference

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach

21 January 2018

1 reference

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study

21 January 2018

1 reference

Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda

21 January 2018

1 reference

Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding

21 January 2018

1 reference

Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study

21 January 2018

1 reference

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials

21 January 2018

1 reference

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission

21 January 2018

1 reference

Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study

21 January 2018

1 reference

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy

21 January 2018

1 reference

Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.

21 January 2018

1 reference

Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

21 January 2018

1 reference

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

21 January 2018

1 reference

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

21 January 2018

1 reference

Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire

21 January 2018

1 reference

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

21 January 2018

1 reference

Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome

21 January 2018

1 reference

Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

21 January 2018

1 reference

Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

21 January 2018

1 reference

Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure

21 January 2018

1 reference

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

21 January 2018

1 reference

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

21 January 2018

1 reference

Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine

21 January 2018

1 reference

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

21 January 2018

1 reference

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

21 January 2018

1 reference

Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study

21 January 2018

1 reference

Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine

21 January 2018

1 reference

Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens

21 January 2018

1 reference

Protease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistance

21 January 2018

1 reference

Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women

21 January 2018

1 reference

Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.

21 January 2018

1 reference

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

21 January 2018

1 reference

Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland

21 January 2018

1 reference

Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial

21 January 2018

1 reference

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants

21 January 2018

1 reference

Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?

21 January 2018

1 reference

Population attributable fractions for late postnatal mother-to-child transmission of HIV-1 in Sub-Saharan Africa

21 January 2018

1 reference

Factors determining HIV viral testing of infants in the context of mother-to-child transmission

21 January 2018

1 reference

Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers

21 January 2018

1 reference

Increasing the uptake of prevention of mother-to-child transmission of HIV services in a resource-limited setting

21 January 2018

1 reference

Family planning among HIV positive and negative prevention of mother to child transmission (PMTCT) clients in a resource poor setting in South Africa

21 January 2018

1 reference

Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection

21 January 2018

1 reference

No relation between in-utero exposure to HAART and intrauterine growth retardation

21 January 2018

1 reference

Transmission Rates in Consecutive Pregnancies Exposed to Single-Dose Nevirapine in Soweto, South Africa and Abidjan, C??te d??Ivoire

21 January 2018

1 reference

Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe

21 January 2018

1 reference

Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000???2006

21 January 2018

1 reference

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

21 January 2018

1 reference

7 January 2021

Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania

1 reference

7 January 2021

Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes

1 reference

7 January 2021

Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

7 January 2021

Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery

1 reference

7 January 2021

Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa

1 reference

7 January 2021

Outcomes of HIV-exposed children in western Kenya: efficacy of prevention of mother to child transmission in a resource-constrained setting

1 reference

7 January 2021

Implementing programs for the prevention of mother-to-child HIV transmission in resource-constrained settings: Horizons studies, 1999-2007

1 reference

7 January 2021

Tolerance and viral resistance after single-dose nevirapine (NVP) and short-course of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) to prevent mother-to-child transmission (PMTCT) of HIV-1: the TEmAA ANRS 12109 phase II trial, step 1

1 reference

7 January 2021

Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008.

9

1 reference

Journal of Acquired Immune Deficiency Syndromes

4 August 2024

33

39

203

Kupka

2005

1 reference

Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe

4 August 2024

36

1 reference

Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen

4 August 2024

98

1 reference

4 August 2024

Identifiers

DOI

10.1586/ERI.10.94

0 references